MYOPIA MANAGEMENT
Helping Children See Further
Myopia is becoming part of childhood for more families around the world and it is often beginning earlier.
MasterVision brings together orthokeratology, personalised lens design, digital fitting, clinical insight, manufacturing, and ongoing practitioner support to help clinicians deliver individualised myopia management over time. The goal is not simply clearer vision today. It is to support each child’s vision as their eyes continue to grow.

See clearly
Care early
Protect tomorrow
Myopia, or short-sightedness, makes distant objects appear blurred. It often begins during the school years and may continue to progress as a child’s eyes grow.
For families, these figures can feel concerning, but they also highlight the value of early, thoughtful care. Children who develop myopia at a younger age have more years in which it may progress, increasing the likelihood of a stronger prescription later in life.

Designed for Individualized Eye
Built for the Clinician
Every eye has its own shape, surface, and fitting characteristics. MasterVision brings together corneal topography, clinical measurements, fitting information, and clinician feedback to support a lens design tailored to the individual eye not simply selected from a standard fit.
By translating complex measurements into a structured digital workflow, the platform helps clinicians make more informed and consistent fitting decisions. It can also reduce unnecessary trial and error, simplify refinements, and make advanced specialty-lens fitting easier to adopt in everyday practice.
The result is a more personalized experience for patients, a clearer workflow for clinicians, and a model that can support more patients without adding the same level of fitting complexity.
From Design to Delivery
Clinical Assessment
Digital Design
Local Manufacturing
Clinical Fitting
Ongoing Management
Platform Capabilities
Orthokeratology, Scleral, RGP
Personalised Lens Design
Digital Fitting
Localized Manufacturing
Clinical Education and Support
Fast Delivery & Warranty
Evidence and Milestones
Regulatory Milestones
China Class III medical-device approval, supported by applicable FDA 510(k)-cleared RGP technologies
Clinical Studies
Ongoing clinical studies and product evaluations with major public hospitals and specialist clinicians in China.
Product Evidence
Clinical cases, product data, and selected study materials are available to qualified partners upon request.
Explore the MasterVision Myopia Platform
